Cellenis

Cellenis is a global leader in autologous cell therapy and Platelet-Rich Plasma (PRP) technology, primarily known for its patented platform used in regenerative medicine and aesthetics. The company's core technology utilizes a proprietary separation gel to produce highly concentrated, pure PRP with minimal red blood cell and granulocyte contamination. Its product portfolio includes Cellenis PRP, Cellenis DermaFiller, and Cellenis TRS, which are used for indications such as skin rejuvenation, hair restoration, and wound management. Cellenis products are FDA-cleared and CE-certified, with a significant commercial presence in the United States and over 60 countries worldwide. The brand is manufactured by Estar Medical and is widely recognized for its single-spin efficiency and clinical safety profile.